Optimark Dosage
Generic name: GADOVERSETAMIDE 0.5mmol in 1mL
Dosage form: injection, solution
Drug class: Magnetic resonance imaging contrast media
Medically reviewed by Drugs.com. Last updated on Apr 22, 2024.
Dosing Guidelines
- Administer Optimark as a bolus peripheral intravenous injection at a dose of 0.2 mL/kg (0.1 mmol/kg) and at a rate of 1 to 2 mL/sec delivered by manual or by power injection (see Table 1).
- Use sterile technique to withdraw and administer Optimark.
- Follow injection with a 5 mL normal saline flush to ensure complete administration of the contrast.
- Discard unused portions of the drug.
|
Table 1 Dosage Chart for Optimark Injection |
|
|
Body Weight |
0.1 mmol/kg |
|
40 |
8 |
|
50 |
10 |
|
60 |
12 |
|
70 |
14 |
|
80 |
16 |
|
90 |
18 |
|
100 |
20 |
|
110 |
22 |
|
120 |
24 |
|
130 |
26 |
|
140 |
28 |
|
150 |
30 |
Drug Handling
- Visually inspect Optimark for particulate matter and discoloration prior to administration. Do not use the solution if it is discolored or particulate matter is present.
- Do not mix Optimark with other medications or parenteral nutrition and do not administer Optimark in the same intravenous line as other medications because of the potential for chemical incompatibility.
Imaging
- Complete the imaging procedure within 1 hour of the injection of Optimark.
- Paramagnetic contrast agents may impair the visualization of lesions seen on non-contrast MRI. Interpret Optimark MR images with companion non-contrast MR images [see Clinical Pharmacology (12.2)].
More about OptiMARK (gadoversetamide)
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- Drug class: magnetic resonance imaging contrast media
- Breastfeeding
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
